Eli Lilly and Co

NYSE:LLYUnited States

Jun 7, 2024

Show headlines and story abstract

• DJ Eli Lilly Is Maintained at Buy by Jefferies, from 1:37PM ET on Friday Jun 07, 2024 by Dow Jones

  1:37PM ET on Friday Jun 07, 2024 by Dow Jones
  Companies Mentioned: LLY
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/LLY/analyst-ratings
  
  (END) Dow Jones Newswires
  
  June 07, 2024 13:37 ET (17:37 GMT)
  

• DJ Germany's Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions - Interview, from 7:55AM ET on Friday Jun 07, 2024 by Dow Jones

  7:55AM ET on Friday Jun 07, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO, PFE, RHHBY, AZN, EXAI, MKKGY
  
  By Helena Smolak and Stefanie Haxel
  
  Germany's Merck KGaA is betting on artificial-intelligence partnerships to develop new drugs, but refraining from bringing in external expertise through acquisitions, the head of the group's healthcare segment said.
  

• DJ FDA AdCom Docs Seen Positive for Lilly's Donanemab -- Market Talk, from 6:39AM ET on Friday Jun 07, 2024 by Dow Jones

  6:39AM ET on Friday Jun 07, 2024 by Dow Jones
  Companies Mentioned: LLY
  
  06:39 ET - Ahead of Monday's FDA advisory committee meeting on Eli Lilly's proposed Alzheimer's disease drug donanemab, the agency releases briefing documents that analysts at William Blair say appear bullish. An FDA decision on whether to approve donanemab as a competitor to Leqembi from Eisai and Biogen had been expected in the first quarter, but the agency in March said it would convene an advisory panel to further discuss the drug. In a research note, William Blair analysts Myles Minter and Sarah Schram say they saw few surprises in the briefing documents, and that while there is a slim chance that the FDA could opt for a label restricting use in tau-positive patients, they think the documents indicate the agency's positive positioning on donanemab. Eli Lilly up 0.3% premarket to $839.50. (colin.kellaher@wsj.com)
  

• Jefferies Adjusts Price Target on Eli Lilly to $957 From $925, from 6:02AM ET on Friday Jun 07, 2024 by MT Newswires

  6:02AM ET on Friday Jun 07, 2024 by MT Newswires
  Companies Mentioned: LLY
  06:02 AM EDT, 06/07/2024 (MT Newswires) -- Eli Lilly and Company (LLY) has an average rating of outperform and price targets ranging from $540 to $1,023, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic...